USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: PHARMACOPHOTONICS, LLC
City: INDIANAPOLIS
State: IN
Zip+4: 46202-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,218,534.00 1
STTR Phase I $103,740.00 1
STTR Phase II $999,981.00 1

Award List:

Non-Invasive Optical Determination of GFR

Award Year / Program / Phase: 2008 / STTR / Phase I
Agency: HHS
Research Institution: N/A
Principal Investigator:
Award Amount: $103,740.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): PharmacoPhotonics, LLC proposes research leading to a novel 2-photon in vivo fluorescence method for monitoring glomerular filtration rate (GFR) in acute kidney injury (AKI). AKI remains a vexing clinical problem result ing in unacceptably high patient mortality,… More

Non-Invasive Optical Determination of GFR

Award Year / Program / Phase: 2009 / STTR / Phase II
Agency: HHS
Research Institution: INDIANA UNIVERSITY
Principal Investigator: Bruce A. Molitoris
Award Amount: $999,981.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): PharmacoPhotonics (FAST Diagnostics), LLC proposes research to extend the Phase I STTR leading to a novel 2-photon in vivo fluorescence method for monitoring glomerular filtration rate (GFR) in acute kidney injury (AKI) . AKI remains a vexing clinical problem… More

Clinical Trial of the FAST Real-Time GFR System

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel Meier – 414-259-2097
Award Amount: $1,218,534.00
Abstract:
DESCRIPTION (provided by applicant): PharmacoPhotonics (DBA FAST, Inc.) proposes Fast-Track research to determine GFR in its first human Pilot study. The long-term goal of this SBIR project is to test FAST's minimally invasive catheter based fluorescent device in humans and commercialize this… More